Tern plc investment Talking Medicines has great synergies across the whole portfolio (Interview)

Tern plc (LON:TERN) CEO Albert Sisto joins DirectorsTalk Interviews to discuss the addition of Talking Medicines to its portfolio. Albert explains what attracted them to the company, how the funds that they have provided will be used and other companies within the portfolio and the synergies across it.

Tern provides venture capital to exciting, high growth IoT innovators in Europe. They provide more than just funding. They provide support and create a genuinely collaborative environment for talented, well-motivated teams, empowering business owners to fulfil their potential for fast growth, market leadership and strong exit multiples.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
DirectorsTalk

More articles like this

Tern plc

How AI-human synergy is rewriting the rules of Pharma Marketing

AI is no longer a futuristic concept in Pharma Marketing—it’s a powerful force already reshaping strategy, precision, and personalisation at scale. But its real magic happens when it partners with human expertise, unlocking smarter, more responsive

Tern plc

Tern advancing innovation in IoT and AI

Tern drives innovation in IoT and AI sectors through strategic investments and collaborations, showcasing its strong momentum in disruptive technologies.